BlackRock Investment Management, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$2,000
-33.3%
4,3260.0%0.00%
Q3 2016$3,000
-50.0%
4,326
+32.7%
0.00%
Q2 2016$6,000
-25.0%
3,2610.0%0.00%
Q1 2016$8,000
-68.0%
3,2610.0%0.00%
Q4 2015$25,000
+47.1%
3,2610.0%0.00%
Q3 2015$17,000
-29.2%
3,261
+22.7%
0.00%
Q2 2015$24,000
+41.2%
2,6580.0%0.00%
Q1 2015$17,000
+70.0%
2,658
+50.9%
0.00%
Q4 2014$10,000
-16.7%
1,7610.0%0.00%
Q3 2014$12,0001,7610.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders